QUOTE AND NEWS
Wall Street Journal  Mar 2  Comment 
Fujifilm’s drug Avigan, which has shown signs of efficacy against the Ebola virus, has drawn interest from about 20 countries and the company stands ready for large orders, its chief executive said.
FiercePharma  Feb 9  Comment 
SINGAPORE--The head of Guinea's Ebola-response program wasted no time in announcing approval of broader use of Fujifilm's Avigan (favipiravir) influenza drug for treating early cases of Ebola in the West Africa nation.
FierceBiotech  Feb 6  Comment 
SINGAPORE--Fujifilm's Toyama Chemical is readying a study for a scientific journal stating that its Avigan (favipiravir) influenza drug has shown promise in treating ebolavirus so far in an early-phase clinical trial in the West African country of...
FierceBiotech  Nov 13  Comment 
Two experimental antivirals are about to undergo snap clinical trials in Africa as doctors scramble to find an effective remedy for the lethal outbreak of Ebola. Doctors Without Borders says that it plans to launch studies of brincidofovir from...
FierceBiotech  Nov 12  Comment 
Fujifilm is confident its recently approved flu treatment can combat the spread of ebolavirus in West Africa, preparing for a surge in manufacturing as it waits on clinical trial results.
Japan Today  Nov 11  Comment 
Fujifilm Holdings Corp said Tuesday it expects its influenza drug Avigan to be approved by international government bodies to treat Ebola as early as the end of the year. Fujifilm has been growing its pharmaceutical division through a series of...
TheStreet.com  Nov 4  Comment 
NEW YORK (TheStreet) -- Shares of Fujifilm Holdings Corp. are down 4.15% to $32.58 in early afternoon trading despite being upgraded to "hold" from "underperform" by Jefferies earlier on Tuesday.  The firm set a price target to $30.78 for the...
Japan Today  Oct 30  Comment 
Japan's Fujifilm Holdings Corp said it was difficult to estimate the profitability of its influenza drug Avigan, which has been earmarked to fight Ebola, given the uncertainty over the spread of virus, a company executive said on...
Wall Street Journal  Oct 30  Comment 
Fujifilm Holdings will prioritize providing its drug Avigan for those suffering from the Ebola disease, but it is difficult to say how that will affect profitability.




 

Based in Tokyo, Fuji Photo Film Company (Fuji Photo) is a leading global producer of photographic imaging products. The company develops, manufactures, and markets traditional and digital imaging products. In addition, Fuji Photo provides services and solutions for consumers, professionals, healthcare providers, and commercial customers. The company's imaging solutions segment, which accounted for 16% of fiscal year 2010 revenue (ending March 2010), focuses on color films, digital cameras, photofinishing equipment, and color paper, chemicals, and services for photofinishing. The company's information solutions segment, which accounted for 41% of fiscal year 2010 revenue, manufactures and markets system devices for graphic arts, medical imaging and information systems, flat panel display materials, and recording media. The company's document solutions segment, which accounted for 43% of fiscal year 2010 revenue, manufactures and markets printers and production systems and provides paper and document services to its customers.[1] Geographically, 48.5% of revenue came from Japan, 16.2% from Europe, 12.3% from the Americas, and 22.9% from Asia and others.[2]

Business Growth

For the fiscal year 2010, Fujifilm's consolidated revenue decreased 10.4% to ¥2.2 trillion from 2009. Despite increased sales of Flat Panel Display (FPD) materials and improvements in the digital camera business, the Imaging Solutions segment experienced a decrease in demand for color films, the information solutions segment had decreased sales in its graphic arts and optical device businesses, and the document solutions experienced lower sales due to lower demand. Overall yen appreciation adversely affected the company.[3]

Key Trends and Forces

Dependency on the Japanese economy

With over half of its revenue deriving from Japan, Fujifilm is highly dependent on Japan's economic condition. Weakness in the Japanese economy may adversely affect its operating results and financial condition, while a strong economy results in increased consumption and higher sales.

Decline of Traditional Film

With the decline of traditional film sales due to the increasing popularity of digital imaging technologies, the company has put a focus on digital technologies. With digital camera sales volume increasing 10%, Fujifilm sold over 9 million digital cameras in 2010. In Japan, over 80% of digital camera demand is replacement demand, and for this reason, Fujifilm has been working to differentiate its cameras through in-house lens development.[4]

Competition

Fujifilm operates in a competitive market with other Japanese and overseas photographic and imaging companies. They include:



References

  1. FUJI 2010 Annual Report Pg. 1
  2. FUJI 2010 Annual Report Pg. 97
  3. FUJI 2010 Annual Report Pg. 44
  4. FUJI 2010 Annual Report Pg. 18
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki